US Stock MarketDetailed Quotes

ELAN Elanco Animal Health

Watchlist
  • 12.060
  • +0.010+0.08%
Close Dec 27 16:00 ET
  • 12.060
  • 0.0000.00%
Post 20:01 ET
5.96BMarket Cap29.41P/E (TTM)

Elanco Animal Health Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-3.56%1.03B
12.02%1.18B
-4.14%1.21B
0.14%4.42B
5.08%1.04B
4.09%1.07B
-10.04%1.06B
2.53%1.26B
-7.41%4.41B
-11.42%985M
Operating revenue
-3.56%1.03B
12.02%1.18B
-4.14%1.21B
0.14%4.42B
5.08%1.04B
4.09%1.07B
-10.04%1.06B
2.53%1.26B
-7.41%4.41B
-11.42%985M
Cost of revenue
1.03%492M
14.06%495M
4.25%515M
0.94%1.93B
15.18%516M
3.18%487M
-10.33%434M
-2.95%494M
-10.27%1.91B
-12.16%448M
Gross profit
-7.40%538M
10.59%689M
-9.57%690M
-0.48%2.49B
-3.35%519M
4.87%581M
-9.84%623M
6.42%763M
-5.09%2.5B
-10.80%537M
Operating expense
0.74%543M
0.70%574M
2.77%557M
2.18%2.16B
-0.59%509M
6.94%539M
2.15%570M
0.18%542M
-9.19%2.11B
-8.41%512M
Selling and administrative expenses
3.19%323M
0.28%354M
3.06%337M
1.58%1.29B
-3.31%292M
5.03%313M
2.92%353M
1.24%327M
-9.84%1.27B
-7.93%302M
Research and development costs
1.16%87M
9.88%89M
7.41%87M
1.87%327M
-1.25%79M
10.26%86M
-1.22%81M
0.00%81M
-13.01%321M
-13.04%80M
Depreciation amortization depletion
-5.00%133M
-3.68%131M
-0.75%133M
3.79%548M
6.15%138M
9.38%140M
2.26%136M
-2.19%134M
-5.04%528M
-6.47%130M
-Depreciation and amortization
-5.00%133M
-3.68%131M
-0.75%133M
3.79%548M
6.15%138M
9.38%140M
2.26%136M
-2.19%134M
-5.04%528M
-6.47%130M
Operating profit
-111.90%-5M
116.98%115M
-39.82%133M
-15.10%326M
-60.00%10M
-16.00%42M
-60.15%53M
25.57%221M
26.32%384M
-41.86%25M
Net non-operating interest income expense
19.44%-58M
12.16%-65M
-3.13%-66M
-14.94%-277M
-8.06%-67M
-20.00%-72M
-10.45%-74M
-23.08%-64M
-2.12%-241M
-12.73%-62M
Non-operating interest expense
-19.44%58M
-12.16%65M
3.13%66M
14.94%277M
8.06%67M
20.00%72M
10.45%74M
23.08%64M
2.12%241M
12.73%62M
Other net income (expense)
158.29%622M
-41.38%-82M
-12.24%-55M
-478.60%-1.24B
-34.62%-70M
-3,038.24%-1.07B
27.50%-58M
0.00%-49M
66.35%-215M
53.98%-52M
Special income (charges)
158.88%623M
-128.57%-80M
-15.00%-46M
-538.80%-1.17B
-16.13%-36M
-3,969.23%-1.06B
59.30%-35M
0.00%-40M
71.14%-183M
65.56%-31M
-Less:Restructuring and merger&acquisition
-81.82%2M
-60.00%14M
15.00%46M
-5.10%93M
-75.00%7M
-59.26%11M
40.00%35M
122.22%40M
-63.97%98M
-73.33%28M
-Less:Impairment of capital assets
-98.57%15M
--61M
----
1,225.93%1.07B
2,800.00%27M
104,800.00%1.05B
--0
----
-76.86%81M
-108.33%-1M
-Less:Other special charges
----
----
----
-50.00%2M
----
----
----
----
-66.67%4M
----
-Write off
--0
--5M
----
----
----
--0
--0
----
----
----
-Gain on sale of business
--640M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
88.89%-1M
91.30%-2M
0.00%-9M
-134.38%-75M
-61.90%-34M
-12.50%-9M
-483.33%-23M
0.00%-9M
-540.00%-32M
8.70%-21M
Income before tax
150.96%559M
59.49%-32M
-88.89%12M
-1,559.72%-1.2B
-42.70%-127M
-2,393.18%-1.1B
-464.29%-79M
44.00%108M
87.39%-72M
28.80%-89M
Income tax
19,600.00%195M
0.00%18M
-500.00%-20M
500.00%36M
140.00%14M
-104.76%-1M
550.00%18M
-79.17%5M
106.82%6M
-105.88%-35M
Net income
133.21%364M
48.45%-50M
-68.93%32M
-1,478.21%-1.23B
-161.11%-141M
-1,586.15%-1.1B
-870.00%-97M
101.96%103M
83.85%-78M
50.00%-54M
Net income continuous Operations
133.21%364M
48.45%-50M
-68.93%32M
-1,478.21%-1.23B
-161.11%-141M
-1,586.15%-1.1B
-870.00%-97M
101.96%103M
83.85%-78M
50.00%-54M
Minority interest income
Net income attributable to the parent company
133.21%364M
48.45%-50M
-68.93%32M
-1,478.21%-1.23B
-161.11%-141M
-1,586.15%-1.1B
-870.00%-97M
101.96%103M
83.85%-78M
50.00%-54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
133.21%364M
48.45%-50M
-68.93%32M
-1,478.21%-1.23B
-161.11%-141M
-1,586.15%-1.1B
-870.00%-97M
101.96%103M
83.85%-78M
50.00%-54M
Basic earnings per share
133.33%0.74
50.00%-0.1
-71.43%0.06
-1,462.50%-2.5
-163.64%-0.29
-1,607.69%-2.22
-900.00%-0.2
110.00%0.21
83.84%-0.16
45.00%-0.11
Diluted earnings per share
132.88%0.73
50.00%-0.1
-71.43%0.06
-1,462.50%-2.5
-163.64%-0.29
-1,607.69%-2.22
-900.00%-0.2
110.00%0.21
83.84%-0.16
45.00%-0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -3.56%1.03B12.02%1.18B-4.14%1.21B0.14%4.42B5.08%1.04B4.09%1.07B-10.04%1.06B2.53%1.26B-7.41%4.41B-11.42%985M
Operating revenue -3.56%1.03B12.02%1.18B-4.14%1.21B0.14%4.42B5.08%1.04B4.09%1.07B-10.04%1.06B2.53%1.26B-7.41%4.41B-11.42%985M
Cost of revenue 1.03%492M14.06%495M4.25%515M0.94%1.93B15.18%516M3.18%487M-10.33%434M-2.95%494M-10.27%1.91B-12.16%448M
Gross profit -7.40%538M10.59%689M-9.57%690M-0.48%2.49B-3.35%519M4.87%581M-9.84%623M6.42%763M-5.09%2.5B-10.80%537M
Operating expense 0.74%543M0.70%574M2.77%557M2.18%2.16B-0.59%509M6.94%539M2.15%570M0.18%542M-9.19%2.11B-8.41%512M
Selling and administrative expenses 3.19%323M0.28%354M3.06%337M1.58%1.29B-3.31%292M5.03%313M2.92%353M1.24%327M-9.84%1.27B-7.93%302M
Research and development costs 1.16%87M9.88%89M7.41%87M1.87%327M-1.25%79M10.26%86M-1.22%81M0.00%81M-13.01%321M-13.04%80M
Depreciation amortization depletion -5.00%133M-3.68%131M-0.75%133M3.79%548M6.15%138M9.38%140M2.26%136M-2.19%134M-5.04%528M-6.47%130M
-Depreciation and amortization -5.00%133M-3.68%131M-0.75%133M3.79%548M6.15%138M9.38%140M2.26%136M-2.19%134M-5.04%528M-6.47%130M
Operating profit -111.90%-5M116.98%115M-39.82%133M-15.10%326M-60.00%10M-16.00%42M-60.15%53M25.57%221M26.32%384M-41.86%25M
Net non-operating interest income expense 19.44%-58M12.16%-65M-3.13%-66M-14.94%-277M-8.06%-67M-20.00%-72M-10.45%-74M-23.08%-64M-2.12%-241M-12.73%-62M
Non-operating interest expense -19.44%58M-12.16%65M3.13%66M14.94%277M8.06%67M20.00%72M10.45%74M23.08%64M2.12%241M12.73%62M
Other net income (expense) 158.29%622M-41.38%-82M-12.24%-55M-478.60%-1.24B-34.62%-70M-3,038.24%-1.07B27.50%-58M0.00%-49M66.35%-215M53.98%-52M
Special income (charges) 158.88%623M-128.57%-80M-15.00%-46M-538.80%-1.17B-16.13%-36M-3,969.23%-1.06B59.30%-35M0.00%-40M71.14%-183M65.56%-31M
-Less:Restructuring and merger&acquisition -81.82%2M-60.00%14M15.00%46M-5.10%93M-75.00%7M-59.26%11M40.00%35M122.22%40M-63.97%98M-73.33%28M
-Less:Impairment of capital assets -98.57%15M--61M----1,225.93%1.07B2,800.00%27M104,800.00%1.05B--0-----76.86%81M-108.33%-1M
-Less:Other special charges -------------50.00%2M-----------------66.67%4M----
-Write off --0--5M--------------0--0------------
-Gain on sale of business --640M------------------0----------------
Other non- operating income (expenses) 88.89%-1M91.30%-2M0.00%-9M-134.38%-75M-61.90%-34M-12.50%-9M-483.33%-23M0.00%-9M-540.00%-32M8.70%-21M
Income before tax 150.96%559M59.49%-32M-88.89%12M-1,559.72%-1.2B-42.70%-127M-2,393.18%-1.1B-464.29%-79M44.00%108M87.39%-72M28.80%-89M
Income tax 19,600.00%195M0.00%18M-500.00%-20M500.00%36M140.00%14M-104.76%-1M550.00%18M-79.17%5M106.82%6M-105.88%-35M
Net income 133.21%364M48.45%-50M-68.93%32M-1,478.21%-1.23B-161.11%-141M-1,586.15%-1.1B-870.00%-97M101.96%103M83.85%-78M50.00%-54M
Net income continuous Operations 133.21%364M48.45%-50M-68.93%32M-1,478.21%-1.23B-161.11%-141M-1,586.15%-1.1B-870.00%-97M101.96%103M83.85%-78M50.00%-54M
Minority interest income
Net income attributable to the parent company 133.21%364M48.45%-50M-68.93%32M-1,478.21%-1.23B-161.11%-141M-1,586.15%-1.1B-870.00%-97M101.96%103M83.85%-78M50.00%-54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 133.21%364M48.45%-50M-68.93%32M-1,478.21%-1.23B-161.11%-141M-1,586.15%-1.1B-870.00%-97M101.96%103M83.85%-78M50.00%-54M
Basic earnings per share 133.33%0.7450.00%-0.1-71.43%0.06-1,462.50%-2.5-163.64%-0.29-1,607.69%-2.22-900.00%-0.2110.00%0.2183.84%-0.1645.00%-0.11
Diluted earnings per share 132.88%0.7350.00%-0.1-71.43%0.06-1,462.50%-2.5-163.64%-0.29-1,607.69%-2.22-900.00%-0.2110.00%0.2183.84%-0.1645.00%-0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.